PRGO Q2 2024 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q2 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.1B-10.7% YoY

Gross Profit

$395M37.0% margin

Operating Income

-$27M-2.5% margin

Net Income

-$108M-10.2% margin

EPS (Diluted)

$-0.77

QoQ Revenue Growth

-1.5%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

-$19M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$10.4B

Total Liabilities

$5.9B

Stockholders' Equity

$4.5B

Cash & Equivalents

$538M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.2B	-10.7%
Gross Profit	$395M	$428M	-7.8%
Operating Income	-$27M	$57M	-146.7%
Net Income	-$108M	$8M	-1390.5%

Revenue Segments

Consumer Self-Care Americas

$634M60%

Consumer Self-Care International

$431M40%

Geographic Segments

UNITED STATES

$628M58%

Europe

$408M38%

Other Geographical Areas

$29M3%

IRELAND

$11M1%